In this study, we found that CHB patients with high-grade hepatic inflammation had significantly increased EBP-1 protein levels compared with those with low-grade hepatic inflammation, suggesting that of EBP-1 upregulation might be associated with liver inflammation in CHB patients. The gene discussed is PA2G4; the disease is inflammatory response.